Valsartan Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 80 mg
Reference Brands: Tiara Solo (Ukraine)
Category:
Heart Disorder
Valsartan is an angiotensin II receptor blocker (ARB) that prevents blood vessel constriction by inhibiting angiotensin II effects. It lowers blood pressure, reduces the risk of stroke and heart failure progression, and supports cardiovascular health. Benefits include improved blood pressure control, reduced cardiac workload, and prevention of cardiovascular events.
Valsartan tablet is available in Tablets
and strengths such as 80 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Valsartan tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Valsartan tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Valsartan tablets, marketed as Diovan, are approved in the US by the FDA and in the EU via EMA for hypertension, heart failure, and reducing cardiovascular risk. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical trial and manufacturing data, while the EMA ensures compliance with regional safety and quality standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports timely approval, safe use, and worldwide availability, helping clinicians manage blood pressure and cardiovascular health effectively across regions.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing